279 related articles for article (PubMed ID: 17913860)
1. Development and evaluation of an Influenza virus subtype H7N2 vaccine candidate for pandemic preparedness.
Pappas C; Matsuoka Y; Swayne DE; Donis RO
Clin Vaccine Immunol; 2007 Nov; 14(11):1425-32. PubMed ID: 17913860
[TBL] [Abstract][Full Text] [Related]
2. Development of Eurasian H7N7/PR8 high growth reassortant virus for clinical evaluation as an inactivated pandemic influenza vaccine.
Jadhao SJ; Achenbach J; Swayne DE; Donis R; Cox N; Matsuoka Y
Vaccine; 2008 Mar; 26(14):1742-50. PubMed ID: 18336962
[TBL] [Abstract][Full Text] [Related]
3. Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies.
Kamal RP; Blanchfield K; Belser JA; Music N; Tzeng WP; Holiday C; Burroughs A; Sun X; Maines TR; Levine MZ; York IA
J Virol; 2017 Oct; 91(20):. PubMed ID: 28768855
[TBL] [Abstract][Full Text] [Related]
4. Protective efficacy of a high-growth reassortant H1N1 influenza virus vaccine against the European Avian-like H1N1 swine influenza virus in mice and pigs.
Ruan BY; Wen F; Gong XQ; Liu XM; Wang Q; Yu LX; Wang SY; Zhang P; Yang HM; Shan TL; Zheng H; Zhou YJ; Tong W; Gao F; Tong GZ; Yu H
Vet Microbiol; 2018 Aug; 222():75-84. PubMed ID: 30080677
[TBL] [Abstract][Full Text] [Related]
5. A live attenuated cold-adapted influenza A H7N3 virus vaccine provides protection against homologous and heterologous H7 viruses in mice and ferrets.
Joseph T; McAuliffe J; Lu B; Vogel L; Swayne D; Jin H; Kemble G; Subbarao K
Virology; 2008 Aug; 378(1):123-32. PubMed ID: 18585748
[TBL] [Abstract][Full Text] [Related]
6. Generation and evaluation of the trivalent inactivated reassortant vaccine using human, avian, and swine influenza A viruses.
Du N; Li W; Li Y; Liu S; Sui Y; Qu Z; Wang Y; Du Y; Xu B
Vaccine; 2008 Jun; 26(23):2912-8. PubMed ID: 18448208
[TBL] [Abstract][Full Text] [Related]
7. Protective efficacy of a bivalent inactivated reassortant H1N1 influenza virus vaccine against European avian-like and classical swine influenza H1N1 viruses in mice.
Ruan BY; Yao Y; Wang SY; Gong XQ; Liu XM; Wang Q; Yu LX; Zhu SQ; Wang J; Shan TL; Zhou YJ; Tong W; Zheng H; Li GX; Gao F; Kong N; Yu H; Tong GZ
Vet Microbiol; 2020 Jul; 246():108724. PubMed ID: 32605742
[TBL] [Abstract][Full Text] [Related]
8. Development of a new candidate H5N1 avian influenza virus for pre-pandemic vaccine production.
Dong J; Matsuoka Y; Maines TR; Swayne DE; O'Neill E; Davis CT; Van-Hoven N; Balish A; Yu HJ; Katz JM; Klimov A; Cox N; Li DX; Wang Y; Guo YJ; Yang WZ; Donis RO; Shu YL
Influenza Other Respir Viruses; 2009 Nov; 3(6):287-95. PubMed ID: 19903211
[TBL] [Abstract][Full Text] [Related]
9. Reassortant H1N1 influenza virus vaccines protect pigs against pandemic H1N1 influenza virus and H1N2 swine influenza virus challenge.
Yang H; Chen Y; Shi J; Guo J; Xin X; Zhang J; Wang D; Shu Y; Qiao C; Chen H
Vet Microbiol; 2011 Sep; 152(3-4):229-34. PubMed ID: 21596495
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of a high-growth reassortant H1N1 influenza virus vaccine against the classical swine H1N1 subtype influenza virus in mice and pigs.
Wen F; Yu H; Yang FR; Huang M; Yang S; Zhou YJ; Li ZJ; Tong GZ
Arch Virol; 2014 Nov; 159(11):2957-67. PubMed ID: 24957653
[TBL] [Abstract][Full Text] [Related]
11. Generation of a reassortant avian influenza virus H5N2 vaccine strain capable of protecting chickens against infection with Egyptian H5N1 and H9N2 viruses.
Kandeil A; Moatasim Y; Gomaa MR; Shehata MM; El-Shesheny R; Barakat A; Webby RJ; Ali MA; Kayali G
Vaccine; 2016 Jan; 34(2):218-224. PubMed ID: 26620838
[TBL] [Abstract][Full Text] [Related]
12. Development of American-Lineage Influenza H5N2 Reassortant Vaccine Viruses for Pandemic Preparedness.
Chen PL; Hu AY; Lin CY; Weng TC; Lai CC; Tseng YF; Cheng MC; Chia MY; Lin WC; Yeh CT; Su IJ; Lee MS
Viruses; 2019 Jun; 11(6):. PubMed ID: 31212631
[TBL] [Abstract][Full Text] [Related]
13. Development of Clade-Specific and Broadly Reactive Live Attenuated Influenza Virus Vaccines against Rapidly Evolving H5 Subtype Viruses.
Boonnak K; Matsuoka Y; Wang W; Suguitan AL; Chen Z; Paskel M; Baz M; Moore I; Jin H; Subbarao K
J Virol; 2017 Aug; 91(15):. PubMed ID: 28490598
[TBL] [Abstract][Full Text] [Related]
14. Intranasal immunization of baculovirus displayed hemagglutinin confers complete protection against mouse adapted highly pathogenic H7N7 reassortant influenza virus.
Rajesh Kumar S; Syed Khader SM; Kiener TK; Szyporta M; Kwang J
PLoS One; 2013; 8(6):e63856. PubMed ID: 23762234
[TBL] [Abstract][Full Text] [Related]
15. A live attenuated H7N7 candidate vaccine virus induces neutralizing antibody that confers protection from challenge in mice, ferrets, and monkeys.
Min JY; Vogel L; Matsuoka Y; Lu B; Swayne D; Jin H; Kemble G; Subbarao K
J Virol; 2010 Nov; 84(22):11950-60. PubMed ID: 20810733
[TBL] [Abstract][Full Text] [Related]
16. Development of a high-yield live attenuated H7N9 influenza virus vaccine that provides protection against homologous and heterologous H7 wild-type viruses in ferrets.
Chen Z; Baz M; Lu J; Paskel M; Santos C; Subbarao K; Jin H; Matsuoka Y
J Virol; 2014 Jun; 88(12):7016-23. PubMed ID: 24719414
[TBL] [Abstract][Full Text] [Related]
17. Generation of an attenuated H5N1 avian influenza virus vaccine with all eight genes from avian viruses.
Shi H; Liu XF; Zhang X; Chen S; Sun L; Lu J
Vaccine; 2007 Oct; 25(42):7379-84. PubMed ID: 17870216
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a genetically modified reassortant H5N1 influenza A virus vaccine candidate generated by plasmid-based reverse genetics.
Subbarao K; Chen H; Swayne D; Mingay L; Fodor E; Brownlee G; Xu X; Lu X; Katz J; Cox N; Matsuoka Y
Virology; 2003 Jan; 305(1):192-200. PubMed ID: 12504552
[TBL] [Abstract][Full Text] [Related]
19. Construction and comparison of different source neuraminidase candidate vaccine strains for human infection with Eurasian avian-like influenza H1N1 virus.
Liu L; Lu J; Zhou J; Li Z; Zhang H; Wang D; Shu Y
Microbes Infect; 2017 Dec; 19(12):635-640. PubMed ID: 28859895
[TBL] [Abstract][Full Text] [Related]
20. A Replication-Defective Influenza Virus Harboring H5 and H7 Hemagglutinins Provides Protection against H5N1 and H7N9 Infection in Mice.
Tian X; Landreth S; Lu Y; Pandey K; Zhou Y
J Virol; 2021 Jan; 95(3):. PubMed ID: 33177192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
